Broadwood moves to oust STAAR Surgical directors over Alcon deal
NegativeFinancial Markets
Broadwood Capital is taking significant steps to remove directors from STAAR Surgical in response to the company's recent deal with Alcon. This move highlights the growing tensions between shareholders and management, as Broadwood believes the deal may not be in the best interest of the company. The outcome of this conflict could have major implications for STAAR's future direction and governance, making it a critical moment for investors and stakeholders alike.
— Curated by the World Pulse Now AI Editorial System